CN1170572C - Medicine for treating atrophic gastritis and chronic colitis and preparation method thereof - Google Patents
Medicine for treating atrophic gastritis and chronic colitis and preparation method thereof Download PDFInfo
- Publication number
- CN1170572C CN1170572C CNB011273054A CN01127305A CN1170572C CN 1170572 C CN1170572 C CN 1170572C CN B011273054 A CNB011273054 A CN B011273054A CN 01127305 A CN01127305 A CN 01127305A CN 1170572 C CN1170572 C CN 1170572C
- Authority
- CN
- China
- Prior art keywords
- weight portions
- medicine
- fructus
- rhizoma
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 56
- 230000001684 chronic effect Effects 0.000 title claims abstract description 16
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 208000016644 chronic atrophic gastritis Diseases 0.000 title claims abstract description 13
- 206010009887 colitis Diseases 0.000 title claims abstract description 13
- 208000004300 Atrophic Gastritis Diseases 0.000 title claims abstract description 10
- 208000036495 Gastritis atrophic Diseases 0.000 title claims abstract description 10
- 229940079593 drug Drugs 0.000 title claims description 11
- 239000002775 capsule Substances 0.000 claims abstract description 8
- 239000006187 pill Substances 0.000 claims abstract description 7
- 238000011282 treatment Methods 0.000 claims description 18
- 238000005303 weighing Methods 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 5
- 238000007796 conventional method Methods 0.000 claims description 3
- 238000012856 packing Methods 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 2
- 238000007873 sieving Methods 0.000 claims description 2
- 244000062241 Kaempferia galanga Species 0.000 abstract description 6
- 230000001225 therapeutic effect Effects 0.000 abstract description 6
- 208000007882 Gastritis Diseases 0.000 abstract description 5
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 241000092665 Atractylodes macrocephala Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 244000124209 Crocus sativus Species 0.000 abstract 1
- 235000015655 Crocus sativus Nutrition 0.000 abstract 1
- 235000002722 Dioscorea batatas Nutrition 0.000 abstract 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 abstract 1
- 240000001811 Dioscorea oppositifolia Species 0.000 abstract 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 abstract 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 abstract 1
- 241000913745 Spatholobus Species 0.000 abstract 1
- 229940126678 chinese medicines Drugs 0.000 abstract 1
- 235000013974 saffron Nutrition 0.000 abstract 1
- 239000004248 saffron Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 14
- 210000002784 stomach Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 235000013421 Kaempferia galanga Nutrition 0.000 description 5
- 208000010643 digestive system disease Diseases 0.000 description 5
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 4
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 4
- 235000005903 Dioscorea Nutrition 0.000 description 4
- 241000234273 Dioscorea Species 0.000 description 4
- 235000000504 Dioscorea villosa Nutrition 0.000 description 4
- 235000004879 dioscorea Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000018522 Gastrointestinal disease Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000001156 gastric mucosa Anatomy 0.000 description 3
- 208000018685 gastrointestinal system disease Diseases 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 208000037902 enteropathy Diseases 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 208000028774 intestinal disease Diseases 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 208000002310 Achlorhydria Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 238000002575 gastroscopy Methods 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 239000009806 pulsatillae Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 description 1
- 229960000620 ranitidine Drugs 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention relates to a medicine for treating atrophic gastritis and chronic colitis and a preparation method thereof. The medicine is capsules or watered pills prepared from Chinese medicines such as saffron, malt, Chinese yam, aucklandia root, hawthorn, smoked plum, coptis root, galanga galangal seed, dried tangerine peel, atractylodes macrocephala, spatholobus stem, etc. The medicine has the advantages of simple production and convenient administration; the medicine has good therapeutic effects on chronic atrophic gastritis, chronic superficial gastritis and chronic colitis.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of gastrointestinal disease, it is to be the Chinese patent medicine of feedstock production with the Chinese herbal medicine specifically, the invention still further relates to the preparation method of this medicine.
Background technology
The people who suffers from gastrointestinal disease is more, therefore there are many medical personnels to devote oneself to the research of this disease, cause these sick medicine listings of existing many treatments, these medicines generally all have characteristics easy to use, but they are not good enough to the therapeutic effect of atrophic gastritis and enteritis, and these medicines also have certain side effect, application number is that 95100455 patent application discloses a kind of " Chinese medicine preparation of treatment chronic colitis " for this reason, this medicament contains Radix Ginseng, the Radix Pulsatillae, the Rhizoma Atractylodis Macrocephalae, Rhizoma Coptidis, Cortex Phellodendri, the Radix Astragali, Fructus Mume, Radix Puerariae, the Radix Angelicae Dahuricae, Halloysitum Rubrum, Poria, the electuary that Chinese herbal medicine such as Radix Glycyrrhizae are made, tablet, all types of medicaments such as capsule, this medicine is better to the colitis curative effect, and have no side effect, but this medicine is to gastritis, atrophic gastritis does not have therapeutical effect.
Summary of the invention
The objective of the invention is to: a kind of medicine with treatment by Chinese herbs stomach, enteropathy is provided, is particularly useful for the medicine of atrophic gastritis and chronic colitis; The present invention also aims to provide the preparation method of this medicine.
Technical scheme of the present invention is based on China's medical science the theory and the principle of treatment digestive system disease is analyzed ingredient and performance with scientific methods, filter out have invigorating the spleen and regulating the stomach, the medicine of the detoxifcation of regulating QI to relieve pain, clearing heat and removing internal wetness, function of promoting blood circulation to disperse blood clots is that feedstock production forms.
The present invention is made by the medicine of following component:
Stigma Croci 8～12 weight portions, Fructus Hordei Germinatus 50～60 weight portions, Rhizoma Dioscoreae 30～40 weight portions,
The Radix Aucklandiae 40～50 weight portions, Fructus Crataegi 40～50 weight portions, Fructus Mume 40～60 weight portions,
Rhizoma Coptidis 30～40 weight portions, Fructus Galangae 10～14 weight portions, Pericarpium Citri Reticulatae 50～60 weight portions,
The Rhizoma Atractylodis Macrocephalae 9～13 weight portions, Caulis Spatholobi 40～50 weight portions.
The present invention is made by the medicine of following component:
Stigma Croci 8～11 weight portions, Fructus Hordei Germinatus 50～55 weight portions, Rhizoma Dioscoreae 33～38 weight portions,
The Radix Aucklandiae 40～42 weight portions, Fructus Crataegi 40～45 weight portions, Fructus Mume 48～52 weight portions,
Rhizoma Coptidis 32～36 weight portions, Fructus Galangae 10～12 weight portions, Pericarpium Citri Reticulatae 50～55 weight portions,
The Rhizoma Atractylodis Macrocephalae 10～12 weight portions, Caulis Spatholobi 40～42 weight portions.
With the method for the medication preparation of above-mentioned component be:
Weight portion by requirement in the component takes by weighing various medicines, Rhizoma Dioscoreae and Fructus Crataegi are dried naturally, then the Radix Aucklandiae, Fructus Hordei Germinatus, Rhizoma Coptidis are toasted under 20 ℃～30 ℃ temperature, Fructus Mume, Stigma Croci are toasted down at 30 ℃～40 ℃, above-mentioned baking crossed with drying in the sun medicine and Pericarpium Citri Reticulatae, the Rhizoma Atractylodis Macrocephalae, Caulis Spatholobi, Fructus Galangae etc. pulverized 100～120 mesh sieves jointly, incapsulate.
The dose of packing in every capsules is 0.45～0.5 gram.
With the method for the medication preparation of above-mentioned component be:
Weight portion by requirement in the component takes by weighing various medicines, Rhizoma Dioscoreae and Fructus Crataegi are dried naturally, then the Radix Aucklandiae, Fructus Hordei Germinatus, Rhizoma Coptidis are toasted under 20 ℃～30 ℃ temperature, Fructus Mume, Stigma Croci are toasted down at 30 ℃～40 ℃, above-mentioned baking crossed with drying in the sun medicine and Pericarpium Citri Reticulatae, the Rhizoma Atractylodis Macrocephalae, Caulis Spatholobi, Fructus Galangae etc. pulverized 100～120 mesh sieves jointly, medicated powder after sieving is made the watered pill according to a conventional method, and the weight of every watered pill is 0.5 gram.
In medicine of the present invention:
Stigma Croci: nature and flavor Gan Xinwen has the effect of promoting blood circulation and breaking stagnation;
Rhizoma Dioscoreae: strengthening the spleen and tonifying the lung is arranged, reinforce the kidney, control the effect of diarrhea due to hypofunction of the spleen;
Fructus Crataegi: can control that meat long-pending does not disappear, gastral cavity portion distending pain; Again can dissipating blood stasis blood, it is better to offset the function that distension is good for the stomach especially;
Rhizoma Coptidis: bitter in the mouth, the effect of pathogenic fire purging, detoxifcation, dampness is arranged, can treat modest tired, the hematodiarrhoea stomachache of heat, strengthen the effect of gastrointestinal function;
Pericarpium Citri Reticulatae: regulate the flow of vital energy the effect that dampness, intestinal stasis relieving, expectorant, treatment distension and fullness of the chest and abdomen, vomiting are had loose bowels;
The Rhizoma Atractylodis Macrocephalae: sweet-bitter flavor, slightly warm in nature, the effect of tonifying the spleen and stomach dampness is arranged, can control the edema and of having loose bowels that can not transmitting and distributing the fluids causes because of weakness of the spleen and stomach because of phlegm-damp stops the distension and fullness of the chest and abdomen that causes, invigorating the spleen and regulating the stomach is arranged, the effect of antidiarrheal antiemetic;
Caulis Spatholobi: bitter in the mouth, little sweet, warm in nature, the effect that having enriches blood invigorates blood circulation;
Fructus Hordei Germinatus: sweet in the mouth, warm in nature, can digest the food that rests in the intestines and stomach, be applicable to the distension and fullness of the chest and abdomen that stagnates and cause because of food stagnation, the effect that also has promoting the circulation of blood and dissipating blood stasis blood to loose and stagnate.
Said medicine is effective in cure for gastrointestinal disease, behind appropriate compatibility, especially chronic atrophic gastritis, chronic superficial gastritis and chronic colitis is had comprehensive therapeutic effect, and the present invention is simple because of making, therefore the also corresponding product price that reduced.
In order to verify the curative effect of Chinese medicine of the present invention, once 1002 cases were observed treatment, 210 routine patients have been diagnosed as for atrophic gastritis through gastroscopy and according to pathological condition, gastric mucosa changer 80 examples are arranged among the 210 routine patients, clear person's 70 examples of gastric mucosa blood vessel, more obvious and achlorhydria person 60 examples of gastric mucosa blood vessel.Suffer from chronic superficial gastritis 600 examples, chronic colitis patient's 192 examples, these patients come off and ulcer for the medicated porridge mucosa through enteroscopy.Male's 589 examples in 1002 patients, women's 413 examples, 18～30 210 examples wherein,
30～45 years old 210 examples, 45～60 years old person's 390 example, person's 192 examples more than 60 years old, in these cases, by being divided into treatment group and matched group at 2: 1, two groups all have comparability at faces such as age, the sex course of disease, clinical settings.
Treatment group: take medicine of the present invention promptly: instructions of taking is obeyed four at every turn, and four times on the one, serve on two courses of treatment, be one month each course of treatment.
Matched group: take empirical medicine ranitidine.
At period in a medicine, two groups of medicines all can be handled at other symptom of patient, but the Chinese medicine of not handy other any treatment digestive system disease or Western medicine.
After two course of therapy, evaluate and treat the evaluation criteria of enteropathy according to the criterion of therapeutical effect in " the clinical research guideline of new Chinese medicine treatment gastropathy " of Ministry of Health of the People's Republic of China's formulation in 1993 and check.Its therapeutic outcome (seeing the following form):
| The treatment group | Matched group | |||||||||||||
| The disease type | The example number | Base more | Produce effects | Effectively | The example number | Base more | Produce effects | Effectively | ||||||
| Chronic superficial gastritis | 400 | Number | Percentage ratio | Number | Percentage ratio | Number | Percentage ratio | 200 | Number | Percentage ratio | Number | Percentage ratio | Number | Percentage ratio |
| 340 | 85％ | 392 | 98％ | 360 | 90％ | 96 | 48％ | 160 | 80％ | 130 | 65％ | |||
| Chronic atrophic gastritis | 140 | 110 | 8％ | 129 | 92％ | 119 | 85％ | 70 | 20 | 28％ | 42 | 60％ | 35 | 50％ |
| Chronic colitis | 128 | 102 | 80％ | 120 | 94％ | 113 | 88％ | 64 | 19 | 30％ | 40 | 62％ | 32 | 50％ |
Embodiment
Be described further below in conjunction with embodiment.
Embodiment 1: take by weighing medicine (is weight portion unit with the kilogram) by following proportioning
8 parts of Stigma Crocis, 60 parts in Fructus Hordei Germinatus, 30 parts of Rhizoma Dioscoreaes,
50 parts of the Radix Aucklandiae, 40 parts of Fructus Crataegis, 30 parts of Rhizoma Coptidis,
60 parts of Fructus Mumes, 50 parts of Pericarpium Citri Reticulataes, 14 parts of Fructus Galangaes,
9 parts of the Rhizoma Atractylodis Macrocephalaes, 40 parts of Caulis Spatholobis.
Preparation method is: Rhizoma Dioscoreae and Fructus Crataegi are dried naturally, the Radix Aucklandiae, Fructus Hordei Germinatus, Rhizoma Coptidis are toasted under 20 ℃～30 ℃ temperature, Fructus Mume, Stigma Croci are toasted down at 30 ℃～40 ℃, again with medicines such as Pericarpium Citri Reticulatae, the Rhizoma Atractylodis Macrocephalae, Caulis Spatholobi, Fructus Galangaes and above-mentioned baking is crossed and the drying in the sun medicine is pulverized jointly, cross 100～120 mesh sieves, then by certain dose branch capsule of packing into, every capsules content is 0.45～5 gram, and this is capsular manufactures and should meet capsule preparations requirement in the Pharmacopoeia of People's Republic of China the 5th edition.
Embodiment 2: take by weighing medicine (is weight portion unit with the gram) by following proportioning
12 parts of Stigma Crocis, 50 parts in Fructus Hordei Germinatus, 40 parts of Rhizoma Dioscoreaes,
40 parts of the Radix Aucklandiae, 50 parts of Fructus Crataegis, 40 parts of Rhizoma Coptidis,
40 parts of Fructus Mumes, 60 parts of Pericarpium Citri Reticulataes, 10 parts of Fructus Galangaes,
13 parts of the Rhizoma Atractylodis Macrocephalaes, 50 parts of Caulis Spatholobis.
Method for production by claim 1 manufactures capsule.
Embodiment 3: take by weighing medicine (is weight portion unit with the kilogram) by following proportioning
11 parts of Stigma Crocis, 55 parts in Fructus Hordei Germinatus, 33 parts of Rhizoma Dioscoreaes,
42 parts of the Radix Aucklandiae, 40 parts of Fructus Crataegis, 32 parts of Rhizoma Coptidis,
48 parts of Fructus Mumes, 55 parts of Pericarpium Citri Reticulataes, 12 parts of Fructus Galangaes,
10 parts of the Rhizoma Atractylodis Macrocephalaes, 42 parts of Caulis Spatholobis.
Preparation method is: the method by embodiment 1 is made powdery with said medicine, then makes watered pill according to a conventional method, and every ball is 5 grams.
Embodiment 4: take by weighing medicine (is weight portion unit with the kilogram) by following proportioning
10 parts of Stigma Crocis, 52 parts in Fructus Hordei Germinatus, 38 parts of Rhizoma Dioscoreaes,
48 parts of the Radix Aucklandiae, 45 parts of Fructus Crataegis, 36 parts of Rhizoma Coptidis,
52 parts of Fructus Mumes, 52 parts of Pericarpium Citri Reticulataes, 11 parts of Fructus Galangaes,
12 parts of the Rhizoma Atractylodis Macrocephalaes, 46 parts of Caulis Spatholobis.
Preparation method by embodiment 3 is made the watered pill.
Claims (5)
1, a kind of medicine for the treatment of atrophic gastritis and chronic colitis, it is characterized in that: it is made up of the medicine of following weight parts:
Stigma Croci 8～12 weight portions, Fructus Hordei Germinatus 50～60 weight portions, Rhizoma Dioscoreae 30～40 weight portions,
The Radix Aucklandiae 40～50 weight portions, Fructus Crataegi 40～50 weight portions, Fructus Mume 40～60 weight portions,
Rhizoma Coptidis 30～40 weight portions, Fructus Galangae 10～14 weight portions, Pericarpium Citri Reticulatae 50～60 weight portions,
The Rhizoma Atractylodis Macrocephalae 9～13 weight portions, Caulis Spatholobi 40～50 weight portions.
2, medicine according to claim 1 is characterized in that: it is made up of the medicine of following weight parts:
Stigma Croci 8～11 weight portions, Fructus Hordei Germinatus 50～55 weight portions, Rhizoma Dioscoreae 33～38 weight portions,
The Radix Aucklandiae 40～42 weight portions, Fructus Crataegi 40～45 weight portions, Fructus Mume 48～52 weight portions,
Rhizoma Coptidis 32～36 weight portions, Fructus Galangae 10～12 weight portions, Pericarpium Citri Reticulatae 50～55 weight portions,
The Rhizoma Atractylodis Macrocephalae 10～12 weight portions, Caulis Spatholobi 40～42 weight portions.
3, a kind of preparation method for the treatment of atrophic gastritis and chronic colitis medicine according to claim 1 and 2 is:
Weight portion by requirement in the component takes by weighing various medicines, Rhizoma Dioscoreae and Fructus Crataegi are dried naturally, then the Radix Aucklandiae, Fructus Hordei Germinatus, Rhizoma Coptidis are toasted under 20 ℃～30 ℃ temperature, Fructus Mume, Stigma Croci are toasted down at 30 ℃～40 ℃, above-mentioned baking crossed with drying in the sun medicine and Pericarpium Citri Reticulatae, the Rhizoma Atractylodis Macrocephalae, Caulis Spatholobi, Fructus Galangae pulverized 100～120 mesh sieves jointly, incapsulate.
4, preparation method according to claim 3 is characterized in that: the dose of packing in every capsules is 0.45～0.5 gram.
5, according to claim 1 or 2 described a kind of preparation methoies for the treatment of the medicine of atrophic gastritis and chronic colitis be:
Take by weighing various medicines by weight, Rhizoma Dioscoreae and Fructus Crataegi are dried naturally, then the Radix Aucklandiae, Fructus Hordei Germinatus, Rhizoma Coptidis are toasted under 20 ℃～30 ℃ temperature, Fructus Mume, Stigma Croci are toasted down at 30 ℃～40 ℃, above-mentioned baking crossed with drying in the sun medicine and Pericarpium Citri Reticulatae, the Rhizoma Atractylodis Macrocephalae, Caulis Spatholobi, Fructus Galangae pulverized 100～120 mesh sieves jointly, medicated powder after sieving is made the watered pill according to a conventional method, and the weight of every watered pill is 0.5 gram.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011273054A CN1170572C (en) | 2001-08-07 | 2001-08-07 | Medicine for treating atrophic gastritis and chronic colitis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB011273054A CN1170572C (en) | 2001-08-07 | 2001-08-07 | Medicine for treating atrophic gastritis and chronic colitis and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1404846A CN1404846A (en) | 2003-03-26 |
| CN1170572C true CN1170572C (en) | 2004-10-13 |
Family
ID=4667279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB011273054A Expired - Fee Related CN1170572C (en) | 2001-08-07 | 2001-08-07 | Medicine for treating atrophic gastritis and chronic colitis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1170572C (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1330361C (en) * | 2004-08-30 | 2007-08-08 | 王庆学 | Chinese medicine special for treating chronic atrophic gastritis |
| CN1318064C (en) * | 2005-01-10 | 2007-05-30 | 孙喜灵 | Medicine for treating chronic atrophic gastritis and its preparation method |
| CN1305396C (en) * | 2005-07-31 | 2007-03-21 | 章建庆 | Process for preparing edible black cardamomum |
| CN101259258B (en) * | 2008-04-14 | 2010-09-29 | 张桂松 | Chinese medicinal composition for treating enteritis |
-
2001
- 2001-08-07 CN CNB011273054A patent/CN1170572C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1404846A (en) | 2003-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101874874B (en) | Chinese medicinal preparation for treating helicobacter pylori concerned chronic gastritis and preparation method thereof | |
| CN101066445A (en) | Chinese medicine prepn for curing gastropathy radically | |
| CN1899500A (en) | Acne clearing decoction | |
| CN1291489A (en) | Chinese medicine for treating baby pneumonia | |
| CN103127422B (en) | Medicament for treating ulcerative colitis | |
| CN102188685B (en) | Externally-applied traditional Chinese medicine powder for treating diarrhea type irritable bowel syndrome and preparation method thereof | |
| CN100336546C (en) | Chinese medicinal preparation for treating gastroenteric disease | |
| CN1170572C (en) | Medicine for treating atrophic gastritis and chronic colitis and preparation method thereof | |
| CN1367003A (en) | Medicine for curing AIDS | |
| CN102038903A (en) | Traditional Chinese medicine for treating acute gastroenteritis | |
| CN1168475C (en) | Chinese herbal medicine composition for treating pyloric spirobacterium infected gastropathy and its production process | |
| CN1814208A (en) | Oral Chinese medicine for treating and preventing recurrence of uecerative stomatitis | |
| CN104740569A (en) | Chinese medicinal umbilical patch for treating infantile diarrhea | |
| CN1213760C (en) | Chinese medicine prepn for treating deficiency of spleen and stomach Yang type atrophic gastritis | |
| CN1163251C (en) | Weishukang for treating gastrosis | |
| CN1114431C (en) | Medicine for treating atrophic gastritis and its preparing process | |
| CN1903347A (en) | Medicine composition for treating alimentary canal diseases, prepn. method and application thereof | |
| CN103054952A (en) | Medicine for treating periodontitis and preparation method thereof | |
| CN101204554B (en) | Medicaments composite for stomach illness and preparation method thereof | |
| CN1336220A (en) | Gastrosis treating Chinese medicine | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN1915400A (en) | Medication for treating symptoms of the illness of nasosinusitis | |
| CN1168482C (en) | Chinese medicine composition for treating enteritis | |
| CN1269518C (en) | Compound medicine for treating tuberculosis and its preparing method | |
| CN102824461A (en) | Medicine for treating hypertension and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20041013 Termination date: 20100807 |